Striatal hypometabolism in premanifest and manifest Huntington’s disease patients (English)
- New search for: López-Mora, D. A.
- New search for: Camacho, V.
- New search for: Pérez-Pérez, J. s.
- New search for: Martínez-Horta, S. l.
- New search for: Fernández, A.
- New search for: Sampedro, F.
- New search for: Montes, A.
- New search for: Lozano-Martínez, G. A.
- New search for: Gómez-Anson, B.
- New search for: Kulisevsky, J.
- New search for: López-Mora, D. A.
- New search for: Camacho, V.
- New search for: Pérez-Pérez, J. s.
- New search for: Martínez-Horta, S. l.
- New search for: Fernández, A.
- New search for: Sampedro, F.
- New search for: Montes, A.
- New search for: Lozano-Martínez, G. A.
- New search for: Gómez-Anson, B.
- New search for: Kulisevsky, J.
In:
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
;
43
, 12
;
2183-2189
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:Striatal hypometabolism in premanifest and manifest Huntington’s disease patients
-
Contributors:López-Mora, D. A. ( author ) / Camacho, V. ( author ) / Pérez-Pérez, J. s. ( author ) / Martínez-Horta, S. l. ( author ) / Fernández, A. ( author ) / Sampedro, F. ( author ) / Montes, A. ( author ) / Lozano-Martínez, G. A. ( author ) / Gómez-Anson, B. ( author ) / Kulisevsky, J. ( author )
-
Published in:EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ; 43, 12 ; 2183-2189
-
Publisher:
- New search for: Springer Science + Business Media
-
Publication date:2016-01-01
-
Size:7 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616 / 610
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 43, Issue 12
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2103
-
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancerCeci, F. / Castellucci, P. / Nanni, C. / Fanti, S. et al. | 2016
- 2105
-
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancerSchwarzenböck, S. M. / Eiber, M. / Kundt, G. n. / Retz, M. / Sakretz, M. / Kurth, J. / Treiber, U. / Nawroth, R. / Rummeny, E. J. / Gschwend, J. r. et al. | 2016
- 2114
-
Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancerPyka, T. / Okamoto, S. / Dahlbender, M. / Tauber, R. / Retz, M. / Heck, M. / Tamaki, N. / Schwaiger, M. / Maurer, T. / Eiber, M. et al. | 2016
- 2122
-
Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligandBoschi, S. / Lee, J. T. / Beykan, S. / Slavik, R. / Wei, L. / Spick, C. / Eberlein, U. / Buck, A. K. / Lodi, F. / Cicoria, G. et al. | 2016
- 2131
-
Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomyRegula, N. / Häggman, M. / Johansson, S. / Sörensen, J. et al. | 2016
- 2139
-
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancerZegers, C. M. / Hoebers, F. J. / Elmpt, W. / Bons, J. A. / Öllers, M. C. / Troost, E. G. / Eekers, D. l. / Balmaekers, L. / Arts-Pechtold, M. / Mottaghy, F. M. et al. | 2016
- 2147
-
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapyOkamoto, S. / Shiga, T. / Yasuda, K. / Watanabe, S. / Hirata, K. / Nishijima, K. i. / Magota, K. / Kasai, K. / Onimaru, R. / Tuchiya, K. et al. | 2016
- 2155
-
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinibHo, K. C. / Fang, Y. H. / Chung, H. W. / Liu, Y. C. / Chang, J. W. / Hou, M. M. / Yang, C. T. / Cheng, N. M. / Su, T. P. / Yen, T. C. et al. | 2016
- 2166
-
ImmunoPET to help stratify patients for targeted therapies and to improve drug developmentKraeber-Bodere, F. o. / Bailly, C. m. / Chérel, M. / Chatal, J. F. et al. | 2016
- 2169
-
ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancerSun, H. / England, C. G. / Hernandez, R. / Graves, S. A. / Majewski, R. L. / Kamkaew, A. / Jiang, D. / Barnhart, T. E. / Yang, Y. / Cai, W. et al. | 2016
- 2180
-
How reliable is 18FDG PET for predicting the onset of Huntington’s disease?Ciarmiello, A. et al. | 2016
- 2183
-
Striatal hypometabolism in premanifest and manifest Huntington’s disease patientsLópez-Mora, D. A. / Camacho, V. / Pérez-Pérez, J. s. / Martínez-Horta, S. l. / Fernández, A. / Sampedro, F. / Montes, A. / Lozano-Martínez, G. A. / Gómez-Anson, B. / Kulisevsky, J. et al. | 2016
- 2190
-
Comparison between MRI-based attenuation correction methods for brain PET in dementia patientsCabello, J. / Lukas, M. / Rota Kops, E. / Ribeiro, A. / Shah, N. J. / Yakushev, I. / Pyka, T. / Nekolla, S. G. / Ziegler, S. I. et al. | 2016
- 2201
-
Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brainFeeney, C. / Scott, G. / Raffel, J. / Roberts, S. / Coello, C. / Jolly, A. / Searle, G. / Goldstone, A. P. / Brooks, D. J. / Nicholas, R. S. et al. | 2016
- 2211
-
Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351Harada, R. / Furumoto, S. / Tago, T. / Katsutoshi, F. / Ishiki, A. / Tomita, N. / Iwata, R. / Tashiro, M. / Arai, H. / Yanai, K. et al. | 2016
- 2219
-
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s diseaseAhmad, R. / Postnov, A. / Bormans, G. / Versijpt, J. / Vandenbulcke, M. / Laere, K. et al. | 2016
- 2228
-
18F-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patientsKim, J. / Choi, K. H. / Song, H. C. / Kim, J. T. / Park, M. S. / Cho, K. H. et al. | 2016
- 2236
-
Feasibility and acceptance of simultaneous amyloid PET/MRISchütz, L. / Lobsien, D. / Fritzsch, D. / Tiepolt, S. / Werner, P. / Schroeter, M. L. / Berrouschot, J. r. / Saur, D. / Hesse, S. / Jochimsen, T. et al. | 2016
- 2244
-
A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonismNiccolini, F. / Politis, M. et al. | 2016
- 2255
-
Guidelines to PET measurements of the target occupancy in the brain for drug developmentTakano, A. / Varrone, A. / Gulyás, B. z. / Salvadori, P. / Gee, A. / Windhorst, A. / Vercouillie, J. / Bormans, G. / Lammertsma, A. A. / Halldin, C. et al. | 2016
- 2263
-
Comments on Van den Wyngaert et al., The EANM practice guidelines for bone scintigraphyStarck, S. k. / Rosendahl, L. et al. | 2016
- 2265
-
Reply to: Starck et al.Wyngaert, T. / Paycha, F. d. et al. | 2016
- 2267
-
Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET)Kameyama, M. / Umeda-Kameyama, Y. et al. | 2016
- 2269
-
99mTc-DPD-scintigraphy with intense uptake in fat tissue caused by AL-amyloidosisZoller, M. / Hajnos, G. / Burkhard, R. / Kneifel, S. et al. | 2016
- 2271
-
Paraneoplastic syndrome demonstrated on 99mTc-HMDP bone scanLancelot, S. / Giammarile, F. / Tescaru, A. et al. | 2016
- 2273
-
In memoriam: Prof. Ignac Fogelman (04.09.1948 – 05.07.2016)Gnanasegaran, G. / Paycha, F. d. / Wyngaert, T. / Israel, O. et al. | 2016